Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1579-1586

  Lee, Icksoo ^a   Hüttemann, Maik ^b,c,d  

^a Dankook University   (South Korea)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Cytochrome c oxidase; Electron transport chain; Haplogroup; Inflammation; Mitochondria; Reactive oxygen species

Indexed keywords

CYTOCHROME C; CYTOCHROME C OXIDASE; MITOCHONDRIAL PROTEIN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; TYROSINE; ANTIOXIDANT; CYTOKINE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; PHOSPHOPROTEIN PHOSPHATASE; SCAVENGER; SUPEROXIDE; TEMPOL; UBIQUINOL CYTOCHROME C REDUCTASE;

AEROBIC METABOLISM; APOPTOSIS; CELL SIGNALING ASSAY; ENERGY METABOLISM; ENZYME ACTIVE SITE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; BURN; CELL PROLIFERATION; CELL SURVIVAL; GENETIC MARKER; HAPLOGROUP; HUMAN; INFLAMMATION; MITOCHONDRIAL ENERGY TRANSFER; MULTIPLE ORGAN FAILURE; NONHUMAN; PREDICTIVE VALUE; RESPIRATORY CHAIN; SEPTIC SHOCK;

CYTOCHROME C OXIDASE; ELECTRON TRANSPORT CHAIN; HAPLOGROUP; INFLAMMATION; MITOCHONDRIA; REACTIVE OXYGEN SPECIES;

ANIMALS; CELL RESPIRATION; ENERGY METABOLISM; HUMANS; INFLAMMATION; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; SEPSIS;

EID: 84903747999     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.031     Document Type: Review

References (119)

1. Ruggieri A.J., Levy R.J., Deutschman C.S. Mitochondrial dysfunction and resuscitation in sepsis. Crit. Care Clin. 2010, 26:567-575. (x-xi).
2. Linde-Zwirble W.T., Angus D.C. Severe sepsis epidemiology: sampling, selection, and society. Crit. Care 2004, 8:222-226.
3. Dick A., Liu H., Zwanziger J., Perencevich E., Furuya E.Y., Larson E., Pogorzelska-Maziarz M., Stone P.W. Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia. BMC Health Serv. Res. 2012, 12:432.
4. Deutschman C.S., Tracey K.J. Sepsis: current dogma and new perspectives. Immunity 2014, 40:463-475.
5. Sankar V., Webster N.R. Clinical application of sepsis biomarkers. J. Anesth. 2013, 27:269-283.
6. Bauer M., Reinhart K. Molecular diagnostics of sepsis-where are we today?. Int. J. Med. Microbiol. 2010, 300:411-413.
7. Marshall J.C., Deitch E., Moldawer L.L., Opal S., Redl H., van der Poll T. Preclinical models of shock and sepsis: what can they tell us?. Shock 2005, 24(Suppl. 1):1-6.
8. Angus D.C., van der Poll T. Severe sepsis and septic shock. N. Engl. J. Med. 2013, 369:840-851.
9. Deitch E.A. Animal models of sepsis and shock: a review and lessons learned. Shock 1998, 9:1-11.
10. Fink M.P., Heard S.O. Laboratory models of sepsis and septic shock. J. Surg. Res. 1990, 49:186-196.
11. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
12. Omachi A., Sharma A.C., Alden K.J., Sam A.D., Ferguson J.L. Induction of peritoneal sepsis increases the susceptibility of isolated hearts to a calcium paradox-mediated injury. Shock 2002, 17:193-198.
13. Brealey D., Karyampudi S., Jacques T.S., Novelli M., Stidwill R., Taylor V., Smolenski R.T., Singer M. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R491-R497.
14. Duvigneau J.C., Piskernik C., Haindl S., Kloesch B., Hartl R.T., Hüttemann M., Lee I., Ebel T., Moldzio R., Gemeiner M., Redl H., Kozlov A.V. A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron-mediated mitochondrial dysfunction. Lab. Invest. 2008, 88:70-77.
15. Regueira T., Djafarzadeh S., Brandt S., Gorrasi J., Borotto E., Porta F., Takala J., Bracht H., Shaw S., Lepper P.M., Jakob S.M. Oxygen transport and mitochondrial function in porcine septic shock, cardiogenic shock, and hypoxaemia. Acta Anaesthesiol. Scand. 2012, 56:846-859.
16. Correa T.D., Vuda M., Blaser A.R., Takala J., Djafarzadeh S., Dunser M.W., Silva E., Lensch M., Wilkens L., Jakob S.M. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit. Care Med. 2012, 40:2841-2849.
17. Patil N.K., Parajuli N., Macmillan-Crow L.A., Mayeux P.R. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am. J. Physiol. Renal Physiol. 2014, 306:F734-F743.
18. Hotchkiss R.S., Song S.K., Neil J.J., Chen R.D., Manchester J.K., Karl I.E., Lowry O.H., Ackerman J.J. Sepsis does not impair tricarboxylic acid cycle in the heart. Am. J. Physiol. 1991, 260:C50-C57.
19. Hotchkiss R.S., Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992, 267:1503-1510.
20. Solomon M.A., Correa R., Alexander H.R., Koev L.A., Cobb J.P., Kim D.K., Roberts W.C., Quezado Z.M., Scholz T.D., Cunnion R.E., et al. Myocardial energy metabolism and morphology in a canine model of sepsis. Am. J. Physiol. 1994, 266:H757-H768.
21. Levy B., Mansart A., Bollaert P.E., Franck P., Mallie J.P. Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med. 2003, 29:292-300.
22. Levy R.J., Vijayasarathy C., Raj N.R., Avadhani N.G., Deutschman C.S. Competitive and noncompetitive inhibition of myocardial cytochrome c oxidase in sepsis. Shock 2004, 21:110-114.
23. Lee I., Salomon A.R., Yu K., Samavati L., Pecina P., Pecinova A., Hüttemann M. Isolation of regulatory-competent, phosphorylated cytochrome c oxidase. Methods Enzymol. 2009, 457:193-210.
24. Yu H., Lee I., Salomon A.R., Yu K., Hüttemann M. Mammalian liver cytochrome c is tyrosine-48 phosphorylated in vivo, inhibiting mitochondrial respiration. Biochim. Biophys. Acta 2008, 1777:1066-1071.
25. Lee I., Salomon A.R., Ficarro S., Mathes I., Lottspeich F., Grossman L.I., Hüttemann M. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 2005, 280:6094-6100.
26. Lee I., Salomon A.R., Yu K., Doan J.W., Grossman L.I., Hüttemann M. New prospects for an old enzyme: mammalian cytochrome c is tyrosine-phosphorylated in vivo. Biochemistry 2006, 45:9121-9128.
27. Helling S., Hüttemann M., Kadenbach B., Ramzan R., Vogt S., Marcus K. Discovering the phosphoproteome of the hydrophobic cytochrome c oxidase membrane protein complex. Methods Mol. Biol. 2012, 893:345-358.
28. Hüttemann M., Helling S., Sanderson T.H., Sinkler C., Samavati L., Mahapatra G., Varughese A., Lu G., Liu J., Ramzan R., Vogt S., Grossman L.I., Doan J.W., Marcus K., Lee I. Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Biochim. Biophys. Acta 2012, 1817:598-609.
29. Helling S., Hüttemann M., Ramzan R., Kim S.H., Lee I., Muller T., Langenfeld E., Meyer H.E., Kadenbach B., Vogt S., Marcus K. Multiple phosphorylations of cytochrome c oxidase and their functions. Proteomics 2012, 12:950-959.
30. Sanderson T.H., Mahapatra G., Pecina P., Ji Q., Yu K., Sinkler C., Varughese A., Kumar R., Bukowski M.J., Tousignant R.N., Salomon A.R., Lee I., Hüttemann M. Cytochrome c is tyrosine 97 phosphorylated by neuroprotective insulin treatment. PLoS One 2013, 8:e78627.
31. Langley R.J., Tsalik E.L., Velkinburgh J.C., Glickman S.W., Rice B.J., Wang C., Chen B., Carin L., Suarez A., Mohney R.P., Freeman D.H., Wang M., You J., Wulff J., Thompson J.W., Moseley M.A., Reisinger S., Edmonds B.T., Grinnell B., Nelson D.R., Dinwiddie D.L., Miller N.A., Saunders C.J., Soden S.S., Rogers A.J., Gazourian L., Fredenburgh L.E., Massaro A.F., Baron R.M., Choi A.M., Corey G.R., Ginsburg G.S., Cairns C.B., Otero R.M., Fowler V.G., Rivers E.P., Woods C.W., Kingsmore S.F. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci. Transl. Med. 2013, 5:1-17. 195ra95.
32. Fredriksson K., Tjader I., Keller P., Petrovic N., Ahlman B., Scheele C., Wernerman J., Timmons J.A., Rooyackers O. Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One 2008, 3:e3686.
33. Hayes M.A., Timmins A.C., Yau E.H., Palazzo M., Hinds C.J., Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 1994, 330:1717-1722.
34. Astiz M., Rackow E.C., Weil M.H., Schumer W. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ. Shock. 1988, 26:311-320.
35. Fink M.P. Bench-to-bedside review: cytopathic hypoxia. Crit. Care 2002, 6:491-499.
36. Dolganiuc A. Cytochrome c oxidase predicts the toll of sepsis. Crit. Care Med. 2011, 39:1552-1554.
37. Duan Z.X., Gu W., Zhang L.Y., Du D.Y., Hu P., Huang J., Liu Q., Wang Z.G., Hao J., Jiang J.X. Clinical relevance of the TLR4 11367 polymorphism in patients with major trauma. Arch. Surg. 2009, 144:1144-1148.
38. Stuber F., Petersen M., Bokelmann F., Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 1996, 24:381-384.
39. Graebin P., Veit T.D., Alho C.S., Dias F.S., Chies J.A. Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patients. Crit. Care 2012, 16:R211.
40. Bracho-Riquelme R.L., Loera-Castaneda V., Torres-Valenzuela A., Loera-Castaneda G.A., Sanchez-Ramirez J.P. Leptin and leptin receptor polymorphisms are associated with poor outcome (death) in patients with non-appendicular secondary peritonitis. Crit. Care 2011, 15:R227.
41. Lehmann L.E., Book M., Hartmann W., Weber S.U., Schewe J.C., Klaschik S., Hoeft A., Stuber F. A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J. Transl. Med. 2009, 7:100.
42. Lorente L., Martin M., Plasencia F., Sole-Violan J., Blanquer J., Labarta L., Diaz C., Borreguero-Leon J.M., Jimenez A., Paramo J.A., Orbe J., Rodriguez J.A., Salido E. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis. Crit. Care 2013, 17:R94.
43. Toubiana J., Courtine E., Pene F., Viallon V., Asfar P., Daubin C., Rousseau C., Chenot C., Ouaaz F., Grimaldi D., Cariou A., Chiche J.D., Mira J.P. IRAK1 functional genetic variant affects severity of septic shock. Crit. Care Med. 2010, 38:2287-2294.
44. Herrnstadt C., Howell N. An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders. Mitochondrion 2004, 4:791-798.
45. Zaragoza M.V., Brandon M.C., Diegoli M., Arbustini E., Wallace D.C. Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. Eur. J. Hum. Genet. 2011, 19:200-207.
46. Coskun P., Wyrembak J., Schriner S.E., Chen H.W., Marciniack C., Laferla F., Wallace D.C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820:553-564.
47. Baudouin S.V., Saunders D., Tiangyou W., Elson J.L., Poynter J., Pyle A., Keers S., Turnbull D.M., Howell N., Chinnery P.F. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 2005, 366:2118-2121.
48. Lorente L., Martin M.M., Lopez-Gallardo E., Iceta R., Sole-Violan J., Blanquer J., Labarta L., Diaz C., Jimenez A., Lafuente N., Hernandez M., Mendez F., Medina N., Ferrer-Aguero J.M., Ferreres J., MC L.L., Mora M.L., Lubillo S., Sanchez-Palacios M., Montoya J., Ruiz-Pesini E. Platelet cytochrome c oxidase activity and quantity in septic patients. Crit. Care Med. 2011, 39:1289-1294.
49. Gomez-Duran A., Pacheu-Grau D., Lopez-Gallardo E., Diez-Sanchez C., Montoya J., Lopez-Perez M.J., Ruiz-Pesini E. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet. 2010, 19:3343-3353.
50. Fetterman J.L., Zelickson B.R., Johnson L.W., Moellering D.R., Westbrook D.G., Pompilius M., Sammy M.J., Johnson M., Dunham-Snary K.J., Cao X., Bradley W.E., Zhang J., Wei C.C., Chacko B., Schurr T.G., Kesterson R.A., Dell'italia L.J., Darley-Usmar V.M., Welch D.R., Ballinger S.W. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume-overload. Biochem. J. 2013, 455:157-167.
51. Crouser E.D., Julian M.W., Blaho D.V., Pfeiffer D.R. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit. Care Med. 2002, 30:276-284.
52. Callahan L.A., Supinski G.S. Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis. J. Appl. Physiol. 2005, 99:1120-1126.
53. Crouser E.D., Julian M.W., Huff J.E., Mandich D.V., Green-Church K.B. A proteomic analysis of liver mitochondria during acute endotoxemia. Intensive Care Med. 2006, 32:1252-1262.
54. Eyenga P., Roussel D., Morel J., Rey B., Romestaing C., Teulier L., Sheu S.S., Goudable J., Negrier C., Viale J.P. Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria. J. Physiol. Biochem. 2014, 70:285-286.
55. Lu S.M., Song S.M., Liu J.C., Yang H.M., Li P., Wang Z.G. Changes of proton transportation across the inner mitochondrial membrane and H(+)-ATPase in endotoxic shock rats. Chin. J. Traumatol. 2003, 6:292-296.
56. Li L., Hu B.C., Chen C.Q., Gong S.J., Yu Y.H., Dai H.W., Yan J. Role of mitochondrial damage during cardiac apoptosis in septic rats. Chin. Med. J. (Engl.) 2013, 126:1860-1866.
57. Chopra M., Sharma A.C. Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sci. 2007, 81:306-316.
58. Messaris E., Memos N., Chatzigianni E., Konstadoulakis M.M., Menenakos E., Katsaragakis S., Voumvourakis C., Androulakis G. Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit. Care Med. 2004, 32:1764-1770.
59. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
60. Piel D.A., Deutschman C.S., Levy R.J. Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 2008, 29:612-616.
61. Piel D.A., Gruber P.J., Weinheimer C.J., Courtois M.R., Robertson C.M., Coopersmith C.M., Deutschman C.S., Levy R.J. Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit. Care Med. 2007, 35:2120-2127.
62. Jones S., Holm T., Mager I., Langel U., Howl J. Characterization of bioactive cell penetrating peptides from human cytochrome c: protein mimicry and the development of a novel apoptogenic agent. Chem. Biol. 2010, 17:735-744.
63. Takakuwa T., Endo S., Nakae H., Kikichi M., Suzuki T., Inada K., Yoshida M. Plasma levels of TNF-alpha, endothelin-1 and thrombomodulin in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 1994, 84:261-269.
64. Newham P., Ross D., Ceuppens P., Das S., Yates J.W., Betts C., Reens J., Randall K.J., Knight R., McKay J.S. Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-alpha (TNF-alpha) using AZD9773, an anti-TNF-alpha immune Fab, in murine CLP sepsis. Inflamm. Res. 2014, 63:149-160.
65. Rondon E., Venkataraman R. Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care 2005, 9:E20.
66. Lee M.D., Zentella A., Vine W., Pekala P.H., Cerami A. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:2590-2594.
67. Tracey K.J., Lowry S.F., Fahey T.J., Albert J.D., Fong Y., Hesse D., Beutler B., Manogue K.R., Calvano S., Wei H., Cerami A., Shires G.T. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 1987, 164:415-422.
68. Samavati L., Lee I., Mathes I., Lottspeich F., Hüttemann M. Tumor necrosis factor α inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J. Biol. Chem. 2008, 283:21134-21144.
69. Gellerich F.N., Trumbeckaite S., Hertel K., Zierz S., Muller-Werdan U., Werdan K., Redl H., Schlag G. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock 1999, 11:336-341.
70. Li C.M., Chen J.H., Zhang P., He Q., Yuan J., Chen R.J., Cheng X.J., Tan H.Z., Yang Y. Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth. Intensive Care 2007, 35:911-919.
71. Choumar A., Tarhuni A., Letteron P., Reyl-Desmars F., Dauhoo N., Damasse J., Vadrot N., Nahon P., Moreau R., Pessayre D., Mansouri A. Lipopolysaccharide-induced mitochondrial DNA depletion. Antioxid. Redox Signal. 2011, 15:2837-2854.
72. Garrabou G., Moren C., Lopez S., Tobias E., Cardellach F., Miro O., Casademont J. The effects of sepsis on mitochondria. J. Infect. Dis. 2012, 205:392-400.
73. Peruchi B.B., Petronilho F., Rojas H.A., Constantino L., Mina F., Vuolo F., Cardoso M.R., Goncalves C.L., Rezin G.T., Streck E.L., Dal-Pizzol F. Skeletal muscle electron transport chain dysfunction after sepsis in rats. J. Surg. Res. 2011, 167:e333-e338.
74. Covian R., Balaban R.S. Cardiac mitochondrial matrix and respiratory complex protein phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H940-H966.
75. Callahan L.A., Supinski G.S. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am. J. Respir. Crit. Care Med. 2005, 172:861-868.
76. Supinski G.S., Callahan L.A. Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weakness. J. Appl. Physiol. 2011, 110:199-205.
77. Supinski G.S., Ji X.Y., Callahan L.A. p38 Mitogen-activated protein kinase modulates endotoxin-induced diaphragm caspase activation. Am. J. Respir. Cell Mol. Biol. 2010, 43:121-127.
78. Supinski G.S., Ji X., Callahan L.A. The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R825-R834.
79. Hanawa N., Shinohara M., Saberi B., Gaarde W.A., Han D., Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J. Biol. Chem. 2008, 283:13565-13577.
80. Schroeter H., Boyd C.S., Ahmed R., Spencer J.P., Duncan R.F., Rice-Evans C., Cadenas E. c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: new target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem. J. 2003, 372:359-369.
81. Chambers J.W., Howard S., LoGrasso P.V. Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo. J. Biol. Chem. 2013, 288:1079-1087.
82. Zhou Q., Lam P.Y., Han D., Cadenas E. c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J. Neurochem. 2008, 104:325-335.
83. Neviere R., Hassoun S.M., Decoster B., Bouazza Y., Montaigne D., Marechal X., Marciniak C., Marchetti P., Lancel S. Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction. Crit. Care Med. 2010, 38:2031-2036.
84. Nagase T., Murakami T., Nozaki H., Inoue R., Nishito Y., Tanabe O., Usui H., Takeda M. Tissue and subcellular distributions, and characterization of rat brain protein phosphatase 2A containing a 72-kDa delta/B″ subunit. J. Biochem. 1997, 122:178-187.
85. Merrill R.A., Slupe A.M., Strack S. N-terminal phosphorylation of protein phosphatase 2A/Bbeta2 regulates translocation to mitochondria, dynamin-related protein 1 dephosphorylation, and neuronal survival. FEBS J. 2013, 280:662-673.
86. Dagda R.K., Merrill R.A., Cribbs J.T., Chen Y., Hell J.W., Usachev Y.M., Strack S. The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit Bbeta2 antagonizes neuronal survival by promoting mitochondrial fission. J. Biol. Chem. 2008, 283:36241-36248.
87. Fang K., Li H.F., Hsieh C.H., Li D.Y., Song D.C., Cheng W.T., Guo Z.X. Differential autophagic cell death under stress with ectopic cytoplasmic and mitochondrial-specific PPP2R2B in human neuroblastoma cells. Apoptosis 2013, 18:627-638.
88. Cheng W.T., Guo Z.X., Lin C.A., Lin M.Y., Tung L.C., Fang K. Oxidative stress promotes autophagic cell death in human neuroblastoma cells with ectopic transfer of mitochondrial PPP2R2B (Bbeta2). BMC Cell Biol. 2009, 10:91.
89. Nakai K., Horton P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem. Sci. 1999, 24:34-36.
90. Kim T.Y., Wang D., Kim A.K., Lau E., Lin A.J., Liem D.A., Zhang J., Zong N.C., Lam M.P., Ping P. Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol. Cell. Proteomics 2012, 11:1586-1594.
91. Taylor D.E., Ghio A.J., Piantadosi C.A. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch. Biochem. Biophys. 1995, 316:70-76.
92. Nethery D., DiMarco A., Stofan D., Supinski G. Sepsis increases contraction-related generation of reactive oxygen species in the diaphragm. J. Appl. Physiol. 1999, 87:1279-1286.
93. Zapelini P.H., Rezin G.T., Cardoso M.R., Ritter C., Klamt F., Moreira J.C., Streck E.L., Dal-Pizzol F. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion 2008, 8:211-218.
94. Supinski G.S., Murphy M.P., Callahan L.A. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1095-R1102.
95. Rocha M., Herance R., Rovira S., Hernandez-Mijares A., Victor V.M. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect. Disord. Drug Targets 2012, 12:161-178.
96. Galley H.F. Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 2011, 107:57-64.
97. Skulachev V.P. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Mosc) 2007, 72:1385-1396.
98. Yang Y., Karakhanova S., Soltek S., Werner J., Philippov P.P., Bazhin A.V. In vivo immunoregulatory properties of the novel mitochondria-targeted antioxidant SkQ1. Mol. Immunol. 2012, 52:19-29.
99. Rottenberg H., Covian R., Trumpower B.L. Membrane potential greatly enhances superoxide generation by the cytochrome bc1 complex reconstituted into phospholipid vesicles. J. Biol. Chem. 2009, 284:19203-19210.
100. Sena L.A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman D.A., Wang C.R., Schumacker P.T., Licht J.D., Perlman H., Bryce P.J., Chandel N.S. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 2013, 38:225-236.
101. Zmijewski J.W., Lorne E., Banerjee S., Abraham E. Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L624-L634.
102. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P.G. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
103. Mascarenhas D.D., Elayadi A., Singh B.K., Prasai A., Hegde S.D., Herndon D.N., Finnerty C.C. Nephrilin peptide modulates a neuroimmune stress response in rodent models of burn trauma and sepsis. Int. J. Burns Trauma 2013, 3:190-200.
104. Zhao X., Leon I.R., Bak S., Mogensen M., Wrzesinski K., Hojlund K., Jensen O.N. Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol. Cell. Proteomics 2011, 10:1-14. (M110.000299).
105. Pecina P., Borisenko G.G., Belikova N.A., Tyurina Y.Y., Pecinova A., Lee I., Samhan-Arias A.K., Przyklenk K., Kagan V.E., Hüttemann M. Phosphomimetic substitution of cytochrome c tyrosine 48 decreases respiration and binding to cardiolipin and abolishes ability to trigger downstream caspase activation. Biochemistry 2010, 49:6705-6714.
106. Kong X., Thimmulappa R., Kombairaju P., Biswal S. NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J. Immunol. 2010, 185:569-577.
107. Knab S., Mushak T.M., Schmitz-Esser S., Horn M., Haferkamp I. Nucleotide parasitism by Simkania negevensis (Chlamydiae). J. Bacteriol. 2011, 193:225-235.
108. Dare A.J., Phillips A.R., Hickey A.J., Mittal A., Loveday B., Thompson N., Windsor J.A. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic. Biol. Med. 2009, 47:1517-1525.
109. Choi H.M., Jo S.K., Kim S.H., Lee J.W., Cho E., Hyun Y.Y., Cha J.J., Kang Y.S., Cha D.R., Cho W.Y., Kim H.K. Glucocorticoids attenuate septic acute kidney injury. Biochem. Biophys. Res. Commun. 2013, 435:678-684.
110. Hüttemann M., Lee I., Grossman L.I., Doan J.W., Sanderson T.H. Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease. Adv. Exp. Med. Biol. 2012, 748:237-264.
111. Salvi M., Brunati A.M., Bordin L., La Rocca N., Clari G., Toninello A. Characterization and location of Src-dependent tyrosine phosphorylation in rat brain mitochondria. Biochim. Biophys. Acta 2002, 1589:181-195.
112. Miyazaki T., Neff L., Tanaka S., Horne W.C., Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 2003, 160:709-718.
113. Ogbi M., Johnson J.A. Protein kinase Cε interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem. J. 2006, 393:191-199.
114. Ogbi M., Chew C.S., Pohl J., Stuchlik O., Ogbi S., Johnson J.A. Cytochrome c oxidase subunit IV as a marker of protein kinase Cε function in neonatal cardiac myocytes: implications for cytochrome c oxidase activity. Biochem. J. 2004, 382:923-932.
115. Acin-Perez R., Salazar E., Kamenetsky M., Buck J., Levin L.R., Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 2009, 9:265-276.
116. Salvi M., Stringaro A., Brunati A.M., Agostinelli E., Arancia G., Clari G., Toninello A. Tyrosine phosphatase activity in mitochondria: presence of Shp-2 phosphatase in mitochondria. Cell. Mol. Life Sci. 2004, 61:2393-2404.
117. Neel B.G., Gu H., Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 2003, 28:284-293.
118. Lee I., Pecinova A., Pecina P., Neel B.G., Araki T., Kucherlapati R., Roberts A.E., Hüttemann M. A suggested role for mitochondria in Noonan syndrome. Biochim. Biophys. Acta 2010, 1802:275-283.
119. Tsukihara T., Aoyama H., Yamashita E., Tomizaki T., Yamaguchi H., Shinzawa-Itoh K., Nakashima R., Yaono R., Yoshikawa S. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8Å. Science 1996, 272:1136-1144.